Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda ...

New research has revealed nearly 300 previously unknown genetic links to depression, in the world’s largest and most diverse ...

The narcolepsy treatment market is projected to grow from USD 5,301.6 million in 2024 to USD 8,718.3 million by 2034, at a ...

The largest and most diverse genetic study of depression has identified 300 new genetic risk factors for the condition across ...

Scientists said the British-led study provides more hope than ever before that the condition could be tackled through new ...

Researchers from the University of Edinburgh and King’s College London believe the findings offer new insight into the ...

The Dutch device firm is touting the results of its sleep diagnostic trials finding its sleep device comparable with in-lab tests.

Harmony Biosciences Holdings, Inc. today announced strong preliminary, unaudited net product revenues for Q4 and full year 2024 of $201 million and $714 million, respectively. Building on this ...

Auvelity preliminary 4Q and full year 2024 net product sales of $92.6 million and $291.4 million, respectively Sunosi ...

At the start of each of the last five years, the share price of Alkermes has increased. It’s the kind of steady trajectory ...

Many of us feel drowsy during the day, but what causes it, and what can we do about it when it becomes a problem? Sleep ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.